Skip to main content
. 2017 Aug 29;8(44):76574–76586. doi: 10.18632/oncotarget.20580

Table 3. Details of primary antibody used in this study.

S. No Antibody Catalog# Host Clonality Company Dilutions* Dilutions
1 CXCR4 NB600-786 Rabbit Polyclonal Novus Bio 1:500 1:1000
2 β-actin 4967S Rabbit Polyclonal CST - 1:1000
3 VEGF-A Sc-507 Rabbit Polyclonal SCB 1:500 1:1000
4 CD31 Ab28364 Rabbit Polyclonal abcam 1:200 -
5 E-cadherin Sc-7870 Rabbit Polyclonal SCB 1:200 1:1000
6 Vimentin 3932S Rabbit Polyclonal CST 1:500 1:1000
7 Fibrinectin F3648 Rabbit Polyclonal Sigma-Aldrich - 1:1000
8 GSK3-3β 9323P Rabbit Monoclonal CST - 1:1000
9 p53 628202 Mouse Monoclonal BioLegend 1:200 1:1000
10 Akt 9271 Rabbit Polyclonal CST 1:25 1:1000
11 Erk 9106 Mouse Monoclonal CST 1;100 1:1000
12 CREB 9198 Rabbit Monoclonal CST 1:200 1:200
13 Hsp27 9709P Rabbit Monoclonal CST - 1:200
14 Stat3 9145 Rabbit Monoclonal CST 1:100 -
15 MapKaPK-2 3007P Rabbit Monoclonal CST - 1:200
16 SEK1/MKK4 9156 Rabbit Polyclonal CST - 1:1000
17 p38 MAPK 9211 Rabbit Polyclonal CST - 1:1000
18 MEK 9121 Rabbit Polyclonal CST - 1:1000

IHC; Immunohistochemistry, IF; Immunofluorescence, WB; Western Blot, Novus Bio; Novus Biologicals, CST; Cell Signaling Technology, SCB; Santa Cruz Biotechnology, *; Dilutions for IHC/IF, ¶; Dilutions for WB.